NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000000689

Registered date:31/03/2008

Effect of pioglitazone on renal function amelioration by measurement of cystatine C levels in the type 2 diabetic patients

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedDiabetic nephropathy
Date of first enrollment2007/05/01
Target sample size70
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)pioglitazone 15-30mg/day metformin 750mg/day

Outcome(s)

Primary Outcomecystatine C, creatinine clearance, albumin extcretion rate, creatinine
Secondary Outcomegeneral biochemical tests, HOMA-R, fasting blood insulin, serum resistin, CRP, adiponectin, leptin levels

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum75years-old
GenderMale and Female
Include criteria
Exclude criteria1)The patient that it is already taken thiazolidinedione. 2)The patient with serious liver functional dysfunction. 3)Gravida or the patient with pregnant likelihood. 4)It is the patient with irritation for thiazolidinedione.

Related Information

Contact

public contact
Name EITARO NAKASHIMA
Address 65 Tsurumai-cho, Showa-ku, Nagoya Japan
Telephone 052-744-2142
E-mail eitaro@med.nagoya-u.ac.jp
Affiliation Nagoya University Hospital Department of Endocrinology and Diabetes
scientific contact
Name EITARO NAKASHIMA
Address 65 Tsurumai-cho, Showa-ku, Nagoya Japan
Telephone 052-744-2142
E-mail
Affiliation Nagoya University Graduate School of Medicine Department of Endocrinology and Diabetes